fda bpc-157 warning letter compounding to weigh easing limits on unproven peptides favored by RFK Jr An FDA advisory committee voted

An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA Peptide Compounding Policy Shift Under RFK Jr. Paul Knoepfler posted on the topic LinkedIn The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link An FDA panel will consider whether to allow compounding pharmacies to manufacture certain peptides. Here's what to know about their safety and efficacy. FDA's Overreach on Compounded Peptides

SKU: 91016129655 · From uqtrucking.com